SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Mercury Laboratories

BSE: 538964 29 Jun 2025
Healthcare
₹ 826.2
Mercury Laboratories Limited specializes in Pharmaceuticals within the Healthcare sector.

Mercury Laboratories - Share Price & Details

Market Cap
₹99.5
High /Low
1,190 / 736.0
Stock P/E
31.7
Book Value
₹446.0
Dividend Yield
0.42
ROCE
9.03
ROE
₹6.01
Face Value
10.0
PEG Ratio
-56.6
EVEBITDA
₹12.7
Debt
5.45
CMP / FCF
-177.0
Debt to equity
₹0.1
NP Ann
3.14
High price all time
1,303
Piotroski score
₹5.0
Graham Number
513.0
No. Eq. Shares
0.12
Net CF
₹-6.03
Net profit
3.14
Price to book value
1.86
Interest Coverage
₹9.47
Low price all time
32.5
Industry PE
32.0
Reserves
₹52.4
Free Cash Flow
₹-5.04

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Mercury Laboratories LimitedNANANANA99.531.7
Hemant Surgical Industries LimNANANANA9912.2
IND-SWIFT LTD.NANANANA94.51.47

Peer Comparison Chart


About Mercury Laboratories

Mercury Laboratories Limited, with Security Code 538964, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Mercury Laboratories Faces Valuation Shift Amid Declining Profits and Market Performance

(20 May 2025)
Mercury Laboratories, a microcap in the Pharmaceuticals & Biotechnology sector, has recently experienced a change in its evaluation.
Read more →

Mercury Labs Standalone March 2025 Net Sales at Rs 20.66 crore, up 18.95% Y-o-Y

(15 May 2025)
Net Sales at Rs 20.66 crore in March 2025 up 18.95% from Rs. 17.37 crore in March 2024. Story continues below Advertisement.
Read more →

Mercury Laboratories Limited recommends final dividend of Rs. 3.50

(15 May 2025)
The Board of Directors of Mercury Laboratories Limited has recommended final dividend @ 35% (Rs 3.50 per share) on the Equity Share Capital...
Read more →

Mercury Laboratories standalone net profit declines 41.88% in the March 2025 quarter

(15 May 2025)
Sales rise 18.94% to Rs 20.66 crore. Net profit of Mercury Laboratories declined 41.88% to Rs 1.11 crore in the quarter ended March 2025 as against Rs 1.91...
Read more →

Mercury Laboratories Reports Record Sales Amid Declining Profitability in May 2025 Results

(15 May 2025)
Mercury Laboratories has reported its financial results for the quarter ending March 2025, achieving its highest quarterly net sales in five...
Read more →

Q4 results today: HAL, Eicher Motors, Tata Power on May 14; full list here

(15 May 2025)
Q4 FY25 company results today: Muthoot Finance, Torrent Power, and Hitachi Energy will be among 126 companies to post earnings reports for...
Read more →